SPIO-enhanced magnetic resonance imaging study of placental perfusion in a rat model of intrauterine growth restriction

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 5, 2012, Pages 626-633

  Deloison, B ^a,b   Siauve, N ^a,b   Aimot, S ^a   Balvay, D ^a   Thiam, R ^a   Cuenod, C A ^a,b   Ville, Y ^b   Clement, O ^a,b   Salomon, L J ^a,b  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Functional MRI; intrauterine growth restriction; microcirculation; placenta; SPIO

Indexed keywords

FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; GESTATIONAL AGE; HEART LEFT VENTRICLE; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA; PLACENTA PERFUSION; PRIORITY JOURNAL; RAT; UTERINE BLOOD VESSEL;

ANIMALS; CONTRAST MEDIA; DEXTRANS; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETITE NANOPARTICLES; MICROCIRCULATION; PLACENTAL CIRCULATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84858450642     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03251.x     Document Type: Article

References (40)

1. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al., Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 339: 667-71.
2. Tsatsaris V, Fournier T, Winer N,. [Pathophysiology of preeclampsia]. J Gynecol Obstet Biol Reprod (Paris) 2008; 37: 16-23.
3. Kovo M, Schreiber L, Ben-Haroush A, Wand S, Golan A, Bar J,. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010; 202: 561 e1-5.
4. Konje JC, Bell SC, Taylor DJ,. Abnormal Doppler velocimetry and blood flow volume in the middle cerebral artery in very severe intrauterine growth restriction: is the occurence of reversal of compensatory flow too late? BJOG 2001; 108: 973-9. (Pubitemid 32778594)
5. Flo K, Wilsgaard T, Vartun A, Acharya G,. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG 2010; 117: 837-44.
6. Ferrazzi E, Rigano S, Padoan A, Boito S, Pennati G, Galan HL,. Uterine artery blood flow volume in pregnant women with an abnormal pulsatility index of the uterine arteries delivering normal or intrauterine growth restricted newborns. Placenta 2011; 32: 487-92.
7. Acharya G, Sitras V, Erkinaro T, Makikallio K, Kavasmaa T, Pakkila M, et al., Experimental validation of uterine artery volume blood flow measurement by Doppler ultrasonography in pregnant sheep. Ultrasound Obstet Gynecol 2007; 29: 401-6. (Pubitemid 46632235)
8. Pardi G, Cetin I,. Human fetal growth and organ development: 50 years of discoveries. Am J Obstet Gynecol 2006; 194: 1088-99.
9. Gowland P,. Placental MRI. Semin Fetal Neonatal Med 2005; 10: 485-90. (Pubitemid 41188484)
10. Salomon LJ, Siauve N, Balvay D, Cuenod CA, Vayssettes C, Luciani A, et al., Placental perfusion MR imaging with contrast agents in a mouse model. Radiology 2005; 235: 73-80. (Pubitemid 40432239)
11. Salomon LJ, Siauve N, Taillieu F, Balvay D, Clement O, Vayssettes C, et al., [Placental functional assessment using MRI: mice today, humans tomorrow?]. J Gynecol Obstet Biol Reprod (Paris) 2005; 34: 666-73. (Pubitemid 43274193)
12. Salomon LJ, Siauve N, Taillieu F, Balvay D, Vayssettes C, Frija G, et al., In vivo dynamic MRI measurement of the noradrenaline-induced reduction in placental blood flow in mice. Placenta 2006; 27: 1007-13. (Pubitemid 44204025)
13. Taillieu F, Salomon LJ, Siauve N, Clement O, Faye N, Balvay D, et al., Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. Radiology 2006; 241: 737-45. (Pubitemid 46190539)
14. Gowland PA, Francis ST, Duncan KR, Freeman AJ, Issa B, Moore RJ, et al., In vivo perfusion measurements in the human placenta using echo planar imaging at 0.5 T. Magn Reson Med 1998; 40: 467-73. (Pubitemid 28391909)
15. Francis ST, Duncan KR, Moore RJ, Baker PN, Johnson IR, Gowland PA,. Non-invasive mapping of placental perfusion. Lancet 1998; 351: 1397-9. (Pubitemid 28209998)
16. Moore RJ, Issa B, Tokarczuk P, Duncan KR, Boulby P, Baker PN, et al., In vivo intravoxel incoherent motion measurements in the human placenta using echo-planar imaging at 0.5 T. Magn Reson Med 2000; 43: 295-302. (Pubitemid 30075454)
17. Onishi H, Murakami T, Kim T, Hori M, Hirohashi S, Matsuki M, et al., Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation. J Magn Reson Imaging 2009; 29: 106-11.
18. Reimer P, Balzer T,. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003; 13: 1266-76. (Pubitemid 36790627)
19. Wigglesworth JS,. Experimental growth retardation in the foetal rat. J Pathol Bacteriol 1964; 88: 1-13.
20. Wigglesworth JS,. Pathological and experimental aspects of foetal growth retardation. Proc R Soc Med 1967; 60: 879-81.
21. Plank C, Nusken KD, Menendez-Castro C, Hartner A, Ostreicher I, Amann K, et al., Intrauterine growth restriction following ligation of the uterine arteries leads to more severe glomerulosclerosis after mesangioproliferative glomerulonephritis in the offspring. Am J Nephrol 2010; 32: 287-95.
22. Olivier P, Baud O, Bouslama M, Evrard P, Gressens P, Verney C,. Moderate growth restriction: deleterious and protective effects on white matter damage. Neurobiol Dis 2007; 26: 253-63. (Pubitemid 46436501)
23. Olivier P, Baud O, Evrard P, Gressens P, Verney C,. Prenatal ischemia and white matter damage in rats. J Neuropathol Exp Neurol 2005; 64: 998-1006. (Pubitemid 41668929)
24. Neitzke U, Harder T, Schellong K, Melchior K, Ziska T, Rodekamp E, et al., Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta 2008; 29: 246-54.
25. Kopp AF, Laniado M, Dammann F, Stern W, Gronewaller E, Balzer T, et al., MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 1997; 204: 749-56. (Pubitemid 27369036)
26. Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, et al., Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology 2006; 240: 90-100. (Pubitemid 43902598)
27. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G,. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11: 509-19.
28. Kitajima K, Kuwata Y, Hayashi M, Imanaka K, Kaji Y, Sugimura K,. Ring enhancement on T1-weighted GRE images after ferucarbotran administration for hepatic metastasis: comparison with pathological findings: case report. Radiat Med 2005; 23: 75-9. (Pubitemid 40410228)
29. Reimer P, Muller M, Marx C, Wiedermann D, Muller R, Rummeny EJ, et al., T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration-preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 1998; 209: 831-6. (Pubitemid 28564924)
30. Wacker FK, Reither K, Ebert W, Wendt M, Lewin JS, Wolf KJ,. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs. Radiology 2003; 226: 459-64. (Pubitemid 36313435)
31. Siega-Riz AM, Hartzema AG, Turnbull C, Thorp J, McDonald T, Cogswell ME,. The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: a randomized controlled trial. Am J Obstet Gynecol 2006; 194: 512-9. (Pubitemid 43183710)
32. Balvay D, Tropres I, Billet R, Joubert A, Peoc'h M, Cuenod CA, et al., Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT. Radiology 2009; 250: 692-702.
33. Malassine A,. [Morphological variability and placental function]. Gynecol Obstet Fertil 2001; 29: 489-96.
34. Carter AM,. Animal models of human placentation-a review. Placenta 2007; 28 (Suppl A): S41-7. (Pubitemid 46508694)
35. Carter AM, Enders AC,. Comparative aspects of trophoblast development and placentation. Reprod Biol Endocrinol 2004; 2: 46.
36. Carter AM, Enders AC, Jones CJ, Mess A, Pfarrer C, Pijnenborg R, et al., Comparative placentation and animal models: patterns of trophoblast invasion-a workshop report. Placenta 2006; 27 (Suppl A): S30-3.
37. Marcos HB, Semelka RC, Worawattanakul S,. Normal placenta: gadolinium-enhanced dynamic MR imaging. Radiology 1997; 205: 493-6. (Pubitemid 27467331)
38. Palacios Jaraquemada JM, Bruno C,. Gadolinium-enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology 2000; 216: 610-1. (Pubitemid 30599891)
39. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB,. MRI in the diagnosis of Crohn's disease in two pregnant women. J Clin Gastroenterol 1993; 17: 244-7. (Pubitemid 23304506)
40. Barker G, Cunliffe N, Bardsley WG, D'Souza SW, Donnai P, Boyd RD,. Fetal and maternal blood volumes in shed human placentae: discrepant results comparing morphometry to haemoglobin content. Placenta 1988; 9: 289-96.